Dual Agonist Surrobody Simultaneously Activates Death Receptors DR4 and DR5 to Induce Cancer Cell Death.
Milutinovic S, Kashyap AK, Yanagi T, Wimer C, Zhou S, O'Neil R, Kurtzman AL, Faynboym A, Xu L, Hannum CH, Diaz PW, Matsuzawa S, Horowitz M, Horowitz L, Bhatt RR, Reed JC.
Milutinovic S, et al. Among authors: yanagi t.
Mol Cancer Ther. 2016 Jan;15(1):114-24. doi: 10.1158/1535-7163.MCT-15-0400. Epub 2015 Oct 29.
Mol Cancer Ther. 2016.
PMID: 26516157
Free PMC article.